Loading...
Loading...
Dahlman Rose downgraded Molycorp
MCP from Buy to Hold.
Dahlman Rose commented, "In the company's 8-K, filed alongside its proposed $300MM capital raise announcement, management alluded to an additional $130MM in capex for 2013. We are downgrading Molycorp to Hold from Buy, based on unanticipated additional scaling up of capital requirements."
Molycorp closed at $7.97 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in